Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Nathan, C. Albera, R. du Bois, W. Bradford, U. Costabel, T. King, P. Noble, S. Sahn, D. Valeyre (Falls Church, Brisbane, San Francisco, Durham, Charleston, United States Of America; Turin, Italy; London, United Kingdom; Essen, Germany; Paris, France). 6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID). Eur Respir J 2012; 40: Suppl. 56, 3656

Member's Comments

No comment yet.

Related content which might interest you: Clinical significance of falling oxygen saturation per walking distance (ΔSaO2/6MWD) during six minute walk test (6MWT) in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Comparison of pulmonary function tests (PFTs) and 6-minute walk test (6MWT) in patients with lymphangioleiomyomatosis (LAM) Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 The incremental shuttle walk test (ISW) in patients with bronchiectasis: Response to pulmonary rehabilitation (PR) and minimum clinically important difference (MCID) Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019 Echocardiographic findings in severe chronic obstructive pulmonary disease (COPD) patients who desaturate during 6-minute walking test (6MWT) Source: Annual Congress 2011 - Clinical physiology for clinical problems Year: 2011 FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change Source: Eur Respir J, 55 (5) 1902151; 10.1183/13993003.02151-2019 Year: 2020 6-minute walk test (6MWT) and Sit-to-Stand Test (STST) as outcome parameters in pulmonary rehabilitation (PR) of COPD patients Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity Year: 2015 A six minute walking test (6MWT) derived index (O2-GAP) predicts mortality in IPF Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Effect of continued pirfenidone treatment following a ≥ 15% decline in 6-minute walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis from 3 pivotal studies Source: International Congress 2016 – New and old therapies for chronic lung diseases Year: 2016 The influence of selected sociodemographic parameters on the results of 6-minute walk test (6MWT) in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 243s Year: 2004 Combination of six-minute walk test (6MWT) and exhaled carbon monoxide (eCO) measurement in patients with exogenous allergic alveolitis (EAE) and idiopathic pulmonary fibrosis (IPF) – test of a new approach Source: Eur Respir J 2007; 30: Suppl. 51, 580s Year: 2007 Change in 6-minute walk test can predict prognosis in idiopathic pulmonary fibrosis Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Improvement of 6-minutes walking test (6MWT) and pulmonary functional status after an inpatient pulmonary rehabilitation program (PRP) in moderate-severe and severe COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 244s Year: 2004 6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 1823-1824 Year: 2014 6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 1822-1823 Year: 2014 Is a double 6-minute walk test (6MWT) required as part of the routine assessment of pulmonary rehabilitation (PR) in COPD patients? Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Source: Eur Respir J 2004; 23: 28-33 Year: 2004 6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 1421-1429 Year: 2014 Test-retest reliability for the 30-meter walk test (30mWT) in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes Year: 2010 Change in 6 minute walk distance (6MWD) following a familiarisation test and exercise training in patients with chronic obstructive pulmonary disease (COPD): influence of disability Source: Annual Congress 2008 - Rehabilitation and influencing factors Year: 2008 Stops and its correlation with new measurements during the six-minute walk test in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016